Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Uniswap First Decentralized Exchange to Cross $3 Trillion in Trading Volume May 12, 2025 Next Post Walgreens doubles down on prescription-filling robots to cut costs, free up pharmacists amid turnaround May 13, 2025 Related Posts CHARBONE Hydrogen Announces $2M Convertible Debentures Replacement September 19, 2025 15 Canadian Crypto ETFs in 2025 September 19, 2025 Charbone Hydrogene annonce des debentures convertibles de remplacement de 2M$ September 19, 2025